Quick note – Please take our quarterly reader survey here; just 3 quick questions to help us continue to serve you. Thanks!Thursday’s rocket move upward is exactly the type of session that bears have had nightmares about for years on end. What looked like nothing more than an oversold bounce yesterday to offset some pressure turned into a huge move […]
View gallery.Stocks have been getting hit pretty hard over the last week. The new year has started off somewhat like 2014 did — down.Some individual industries are holding up a little better than others, such as gold miners, REITs and airlines.Biotech stocks have held on relatively well, too.Biotech names such as Agios Pharmaceuticals (NASDAQ: AGIO) and Incyte Corp (NASDAQ: INCY) […]
Sovaldi pill. Source: Gilead SciencesGilead Sciences had another phenomenal year in 2014, returning 26% for investors. That’s more than double the return of the broad-based S&P 500 , and it has hepatitis C drug Sovaldi to thank.In just the first nine months of 2014, Sovaldi netted Gilead $8.55 billion in sales. It’s the most effective drug launch in history by […]
Watch tonight’s video market recap on my Ticker.tv channel, Mark333.Indexes continued their rotten start to 2015 as the S&P 500 fell 0.89% and the NASDAQ 1.29%. Markets opened up and then sellers came in which is not the type of action you want to see during a bull market move – you want the opposite (morning weakness bought!). Oil continues […]
In recent years, there have been many bad times in which to be long biotechnology stocks and exchange traded funds, but with some marquee industry conferences imminent, the biotech industry is in the midst of one of its most potent seasonal periods.December is the second-best month of the year for the broader biotech sector after July, but due to the […]
SAN FRANCISCO (MarketWatch) — Cyberonics Inc. shares declined in the extended session Monday after the medical device maker said its appeal of a medical reimbursement decision was denied.Cyberonics CYBX, +5.49% shares fell 8.1% to $53.10 on moderate volume after an appeals board supported a 2007 decision by the Centers for Medicare and Medicaid that the company’s pacemaker-like device for treating […]
” itemprop=”image”/>Share prices of biotech stocks are hitting the wall at the rate of one a week, with Prana Biotechnology the latest company to suffer. Its shares were dumped on Tuesday after poor research results.The shares dived 74 per cent, hitting the pockets of some of the country’s wealthiest families and wiping out a remarkable surge that had seen its […]
Nanosonics chief Michael Kavanagh wants to build Australia’s next medical device success story, replicating the success of his old employer, bionic ear maker Cochlear. Photo: Louie DouvisAfter a disappointing year for local biotechnology stocks, in which a number of high profile companies faltered on the back of poor clinical results or internal blunders, investors are scouring the sector for the […]
The bull market is nearing six years old. It turns out that the biotech sector again managed a huge outperforming year in 2014 as well. The gains of the key biotech exchange traded funds (ETFs) were up in the 40% range, with the NYSE Arca Biotech index up over 45% year-to-date. The equal-weight biotech ETF performed better than the key larger […]
Benchmarks mostly settled in the green on Tuesday banking on better-than-expected revision to third quarter GDP numbers. The Dow closed above the 18K mark for the first time ever and notched up a record closing level for the 36th time this year. Almost 119 trading sessions have gone by since the index had crossed the 17K mark. The S&P 500 […]
